In an earlier study, we had found in chickens that bevacizumab, an anti-VEGF antibody, suppressed choroidal thickening that normally occurs when eyes recover from induced myopia [28] and localized VEGF to the walls of choroidal blood vessels and in choroidal nerve fiber bundles. The gene discussed is VEGFA; the disease is myopia.